A Problem Solving Intervention Involving Employees at Risk of Sick Leave Due to Common Mental Disorders
PRIME
Early Prevention of Sick Leave at the Workplace: Design of a Cluster-randomized Controlled Trial of a Problem-solving Intervention Among Employees With Common Mental Disorders
1 other identifier
interventional
170
1 country
1
Brief Summary
The overall aim of this randomized controlled trial is to evaluate the effectiveness of a problem-solving intervention for the prevention of sick leave among employees with early signs of CMDs. The intervention is delivered by first-line managers and a 30% reduction in sick leave days is expected in the experimental condition compared to treatment-as-usual, during the 12- months follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2021
CompletedFirst Posted
Study publicly available on registry
July 23, 2021
CompletedStudy Start
First participant enrolled
August 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 27, 2024
March 1, 2024
3.4 years
July 14, 2021
March 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Sick leave
The total number of days on sick leave due to CMDs (including the first 14 calendar days compensated by the employer) during the 12 month follow-up period
From baseline until 12 months
Secondary Outcomes (8)
Work performance
From baseline until the 12-month follow-up
Work ability
From baseline until the 12-month follow-up
Self-rated general health
From baseline until the 12-month follow-up
Depressive and anxiety symptoms
From baseline until the 12-month follow-up
Self-rated exhaustion
From baseline until the 12-month follow-up
- +3 more secondary outcomes
Other Outcomes (3)
General self-efficacy
From baseline until the 12-month follow-up
Manager support
From baseline until the 12-month follow-up
Job control
From baseline until the 12-month follow-up
Study Arms (2)
Problem solving intervention
EXPERIMENTALProblem solving as developed by Nexu and colleguages. First-line managers are trained in the problem solving intervention (1 1/2 day). Thereafter, they apply the problem-solving in 2 - 5 meetings (about 30 - 45 min each) with employees at risk of future sick leave due to common mental disorders.
Care as usual
ACTIVE COMPARATORFirst-line managers participate in a 3 hour lectur including a brief overview about worker health, occupational stress and the mismatch model and self-efficacy. Thereafter, they provide care-as-usual to employees at risk of future sick leave due to common mental disorders.
Interventions
The intervention focuses on the individual employee and his/her work situation and work-private life balance. The following steps are implemented: inventory and prioritization of problems; brainstorming options and solutions; formulation of an action plan; evaluation, and follow-up. The intervention is carried out in about 3 planned meetings (30 - 45 min) between the manager and the employee. However, given the lack of research regarding the intervention delivered to this specific population and which dose that should be considered as beneficial as well as the complexities of the identified problems, the number of meetings is not specified
The managers and the employee have meetings regarding the employee and his/her work situation and work-private life balance. However, the managers are not educated in and do not use the problem solving intervention. They are instead instructed to use their usual procedures.
Eligibility Criteria
You may qualify if:
- scoring with a cut-off ≥3 points on the GHQ-12, or a positive answer on the question on risk of SA, namely employee believes that he/she will receive a sickness certification due to stress, anxiety, or depression the following 12 months.
- negative answer on the question on bullying, namely employee has not been exposed to bullying by his or her first line manager.
- understand written and spoken Swedish.
You may not qualify if:
- Ongoing sick leave (full- or part-time), leave of absence, pregnancy.
- Sick leave ≥14 calendar days during the last 3 months due to CMD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- AFA Insurancecollaborator
Study Sites (1)
Karolinska Institutet
Stockholm, 17177, Sweden
Related Publications (1)
Bjork Bramberg E, Arapovic-Johansson B, Bultmann U, Svedberg P, Bergstrom G. Prevention of sick leave at the workplace: design of a cluster-randomized controlled trial of a problem-solving intervention among employees with common mental disorders. BMC Public Health. 2021 Sep 26;21(1):1756. doi: 10.1186/s12889-021-11786-6.
PMID: 34565357DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabeth Björk-Brämberg@ki.se, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Docent, Associate Professor, PhD
Study Record Dates
First Submitted
July 14, 2021
First Posted
July 23, 2021
Study Start
August 16, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
March 27, 2024
Record last verified: 2024-03